Investigating Critical Issues in the Management of Patients with Severe Asthma

Registration is complimentary and is open to Active Members, Fellows, Interns, and Residents. Space is limited and pre-registration will be required.

Mark your calendars and please join us on Wednesday, January 22, 2020
5:45pm – 6:00pm:  Registration
6:00pm – 6:30pm:  Macro Asset Perspective Talk for Retirement; Tina Yessaie, Financial Services Professional, New York Life & NYLIFE Securities & Arin Moradian, Investment Advisor with Eagle Strategies, LLC
6:30pm – 7:00pm:  LASAACI Business Meeting & Dinner Service
7:00pm – 7:45pm:  Lecture – Investigating Critical Issues in the Management of Patients with Severe Asthma; William W. Busse, MD
7:45pm:  Q&A/Closing Remarks

Faculty Presenter
William W. Busse, MD
Professor of Medicine
Allergy, Pulmonary and Critical Care Medicine
School of Medicine and Public Health
University of Wisconsin
Madison, WI

Learning Objectives:
Upon completion of this educational activity, participants should be able to:

• Review severe asthma phenotypes and endotypes and conduct appropriate biomarker tests to differentiate between phenotypes in patients with severe asthma
• Evaluate the latest evidence supporting the use of biologic therapies for the management of severe asthma
• Incorporate into practice the most recent recommendations for the optimal management of patients with severe asthma
• Implement strategies to minimize the use of oral corticosteroids (OCS) in patients with severe asthma

Accreditation Statement & Credit Designation:
Integrity Continuing Education, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Integrity Continuing Education, Inc. designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Provided by Integrity Continuing Education, Inc.
Supported by an educational grant from Sanofi Genzyme and Regeneron Pharmaceuticals.

Macro Asset Perspective Talk for Retirement

• Tina Yessaie
  • Financial Services Professional with New York Life & NYLIFE Securities
    Specializing in Protection, Retirement & Estate Planning
• Arin Moradian
  • Investment Advisor with Eagle Strategies LLC
    Sepcializing in Retirement and Investment Strategies for Medical Offices